US 11690860
Treatment of HCV infected patients with cirrhosis
granted A61KA61K31/7076A61K31/708
Quick answer
US patent 11690860 (Treatment of HCV infected patients with cirrhosis) held by Atea Pharmaceuticals, Inc. expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Atea Pharmaceuticals, Inc.
- Grant date
- Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/7076, A61K31/708, A61P, A61P1/16